Epiceram for face

Face Epiceram

The EpiCeram helps to repair and heal the skin barrier through a unique mechanism of action that is not common with other medications. Peer-reviewed dermatology article indexed with MEDLINE/PubMed The Icahn School of Medicine at Mount Sinai, New York, NY; Indiana University School of Medicine, Indianapolis, IN; The reparation and servicing of the skin wall is of paramount importance for the management of neurodermatitis (AD). Whilst skin barriers and emolients are seen as the basis of AD therapies, there is little comparison between different drug option products.

It was a small sampling trial to evaluate the use of dermal barriers in comparison to a frequently used moisturizer to enhance the neurodermatitis patient's emotional barriers. In the meantime, it is known that the expidermal barriers serve not only to inhibit the penetration of external agents such as stimulants or allergens, but also to transmit diseases.

While it has long been known that dysfunction of the wall can directly cause AD, most studies today suggest that there is a significant association between malfunction of the wall and irritation of the skins. EpiCeram® Lipid Skin Barrier ( "Skin Barrier")ulsion, Puracap Pharmaceutical, LLC, South Plainfield, New Jersey, is a Food and Drug Administration-approved 510K ethical medicine approved for the management of dehydrated skins and for the management and alleviation of burns and pruritus associated with various kinds of dermatologic disorders such as AD, irritative touch dermatitis and radiated dermatitis.

Benefits of this dermal-barrier emulsion are that it is steroid-free, with no restrictions on the place or length of use and no restrictions on aging. As part of a preliminary trial, the effect of this EpiCeram type moisture removal agent on moisture and TTEWL was determined and compared with the effect of a commercially available petrolatum-based moisturising solution (Eucerin®, Beiersdorf AG, Hamburg, Germany).

New Tretinoin 0. 05% Lotion for the once daily treatment of moderate to severe.....

Auch interessant

Mehr zum Thema